Comparison of gadopentetate dimeglumine and albumin-(Gd-DTPA)30 for microvessel characterization in an intracranial glioma model.
To compare the performance of macromolecular albumin gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)30 and low molecular weight gadopentetate dimeglumine for microvessel characterization, we examined an intracranial 9L glioma model in which increased angiogenesis, hypervascularity, and hyperpermeability mimic characteristics of clinical malignant brain tumors. Dynamic MRI data were analyzed using a bidirectional, two-compartment kinetic model to extract quantitative estimates for fractional blood volume (fBV) and permeability surface area product (PS). Three criteria were used for comparison of contrast agent performance: (a) tumor conspicuity, defined as the contrast-to-noise ratio (CNR); (b) dynamic range of differential permeability estimates between tumor and normal brain; (c) reasonableness of blood volume estimates. Gadopentetate was superior to macromolecular albumin-(Gd-DTPA)30 for detection of 9L brain gliomas and for measurements of hyperpermeability.
Ostrowitzki
S
S
Department of Radiology, University of California San Francisco, 94143, USA.
Fick
J
J
Roberts
T P
TP
Wendland
M F
MF
Aldape
K D
KD
Mann
J S
JS
Israel
M A
MA
Brasch
R C
RC
D000418:Albumins; D000818:Animals; D001921:Brain / Q000098:blood supply / Q000473:pathology*; D001932:Brain Neoplasms / Q000098:blood supply / Q000473:pathology*; D003287:Contrast Media; D019786:Gadolinium DTPA; D005910:Glioma / Q000098:blood supply / Q000473:pathology*; D008279:Magnetic Resonance Imaging; D008833:Microcirculation / Q000502:physiology; D051381:Rats; D011916:Rats, Inbred F344
D000418:Albumins; D003287:Contrast Media; C058946:albumin-(gadolinium-DTPA); D019786:Gadolinium DTPA